Scientific ReportsBiophysicsPeer-reviewed journal article
Minimal system for assembly of SARS-CoV-2 virus like particles
H. Swann, A. Sharma, B. Preece, A. Peterson, C. Eldredge, D. Belnap, M. Vershinin, S. Saffarian
Abstract
SARS-CoV-2 virus is the causative agent of COVID-19. Here we demonstrate that non-infectious SARS-CoV-2 virus like particles (VLPs) can be assembled by co-expressing the viral proteins S, M and E in mammalian cells. The assembled SARS-CoV-2 VLPs possess S protein spikes on particle exterior, making them ideal for vaccine development. The particles range in shape from spherical to elongated with a characteristic size of 129 {+/-} 32 nm. We further show that SARS-CoV-2 VLPs dried in ambient conditions can retain their structural integrity upon repeated scans with Atomic Force Microscopy up to a peak force of 1 nN.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Optimized production and fluorescent labelling of SARS-CoV-2 Virus-Like-Particles to study virus assembly and entry.
D. Muriaux, M. Gourdelier, … C. Favard·bioRxiv·Mar 23, 2022
- Mammalian cells-based platforms for the generation of SARS-CoV-2 virus-like particles
G. Elfayres, R. R. Paswan, … L. Berthoux·bioRxiv·Jul 24, 2023
- Efficient production of Moloney murine leukemia virus-like particles pseudotyped with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein
M. Caruso, S. Roy, … P. O. de Campos-Lima·bioRxiv·Sep 16, 2020
- Multi-Antigenic Virus-like Particle of SARS CoV-2 produced in Saccharomyces cerevisiae as a vaccine candidate
K. Arora, R. Rastogi, … P. K. Kundu·bioRxiv·May 18, 2020
- SARS-CoV2 associated secretion of nanoLuciferase reports on virus and Virus-Like Particle production
Rebekah C. Gullberg, Judith Frydman·bioRxiv·Oct 11, 2022
- SARS-CoV-2 Virus like Particles produced by a single recombinant baculovirus generate potent neutralizing antibody that protects against variant challenge
E. Sullivan, P.-y. Sung, … P. Roy·bioRxiv·Nov 29, 2021